<table id="t300" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.¶</caption>
<col align="left" width="50.000%"></col>
<col align="left" width="15.400%"></col>
<col align="left" width="14.600%"></col>
<col align="left" width="20.000%"></col>
<thead>
<tr><td align="left" valign="top"></td><td align="center" valign="top"><content stylecode="bold">Total body clearance*</content></td><td align="center" valign="top"><content stylecode="bold">Half-life</content></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"></td><td align="center" valign="top"><content stylecode="bold">mean (range)††</content></td><td align="center" valign="top"><content stylecode="bold">mean (range)††</content></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Population characteristics</content></td><td align="center" valign="top"><content stylecode="bold">(mL/kg/min)</content></td><td align="center" valign="top"><content stylecode="bold">(hr)</content></td><td align="left" valign="top"></td></tr>
</thead>
<tfoot>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote">¶ For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</paragraph></td></tr>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote">* Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics.</paragraph></td></tr>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote">†† Reported range or estimated range (mean ±2 SD) where actual range not reported.</paragraph></td></tr>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote">† NR = not reported or not reported in a comparable format.</paragraph></td></tr>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote">** Median</paragraph></td></tr>
<tr><td align="left" colspan="4" valign="top"><paragraph stylecode="footnote"><content stylecode="bold underline">Note</content>: In addition to the factors listed above, theophylline clearance is increased and half-life decreased by low carbohydrate/high protein diets, parenteral nutrition, and daily consumption of charcoal-broiled beef. A high carbohydrate/low protein diet can decrease the clearance and prolong the half-life of theophylline.</paragraph></td></tr>
</tfoot>
<tbody>
<tr><td align="left" valign="top"><content stylecode="bold">Age</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="underline">Premature neonates</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">postnatal age 3-15 days</td><td align="left" valign="top">0.29 (0.09-0.49)</td><td align="left" valign="top">30(17-43)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">postnatal age 25-57 days</td><td align="left" valign="top">0.64 (0.04-1.2)</td><td align="left" valign="top">20 (9.4-30.6)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/><content stylecode="underline">Term infants</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">postnatal age 1-2 days</td><td align="left" valign="top">NR†</td><td align="left" valign="top">25.7 (25-26.5)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">postnatal age 3-30 weeks</td><td align="left" valign="top">NR†</td><td align="left" valign="top">11 (6-29)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/><content stylecode="underline">Children</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">1-4 years</td><td align="left" valign="top">1.7 (0.5-2.9)</td><td align="left" valign="top">3.4 (1.2-5.6)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">4-12 years</td><td align="left" valign="top">1.6 (0.8-2.4)</td><td align="left" valign="top">NR†</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">13-15 years</td><td align="left" valign="top">0.9 (0.48-1.3)</td><td align="left" valign="top">NR†</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">16-17 years</td><td align="left" valign="top">1.4 (0.2-2.6)</td><td align="left" valign="top">3.7 (1.5-5.9)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/><content stylecode="underline">Adults (16-60 years)</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">otherwise healthy</td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">non-smoking asthmatics</td><td align="left" valign="top">0.65 (0.27-1.03)</td><td align="left" valign="top">8.7 (6.1-12.8)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/><content stylecode="underline">Elderly (&gt;60 years)</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">non-smokers with normal cardiac,</td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">liver, and renal function</td><td align="left" valign="top">0.41 (0.21-0.61)</td><td align="left" valign="top">9.8 (1.6-18)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/><content stylecode="underline">Concurrent illness or</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="underline">altered physiological state</content></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Acute pulmonary edema</td><td align="left" valign="top">0.33** (0.07-2.45)</td><td align="left" valign="top">19** (3.1-82)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">COPD - &gt;60 years, stable</td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">non-smoker &gt;1 year</td><td align="left" valign="top">0.54 (0.44-0.64)</td><td align="left" valign="top">11 (9.4-12.6)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>COPD with cor pulmonale</td><td align="left" valign="top">0.48 (0.08-0.88)</td><td align="left" valign="top">NR†</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">Cystic fibrosis (14-28 years)</td><td align="left" valign="top">1.25 (0.31-2.2)</td><td align="left" valign="top">6.0(1.8-10.2)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Fever associated with acute viral respiratory</td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">illness (children 9-15 years)</td><td align="left" valign="top">NR†</td><td align="left" valign="top">7.0 (1.0-13)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Liver disease - cirrhosis</td><td align="left" valign="top">0.31** (0.1-0.7)</td><td align="left" valign="top">32** (10-56)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">acute hepatitis</td><td align="left" valign="top">0.35 (0.25-0.45)</td><td align="left" valign="top">19.2 (16.6-21.8)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">cholestasis</td><td align="left" valign="top">0.65 (0.25-1.45)</td><td align="left" valign="top">14.4 (5.7-31.8)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Pregnancy - 1st trimester</td><td align="left" valign="top">NR†</td><td align="left" valign="top">8.5 (3.1-13.9)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">2nd trimester</td><td align="left" valign="top">NR†</td><td align="left" valign="top">8.8 (3.8-13.8)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">3rd trimester</td><td align="left" valign="top">NR†</td><td align="left" valign="top">13.0 (8.4-17.6)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Sepsis with multi-organ failure</td><td align="left" valign="top">0.47 (0.19-1.9)</td><td align="left" valign="top">18.8 (6.3-24.1)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"><br/>Thyroid disease - hypothyroid</td><td align="left" valign="top">0.38 (0.13-0.57)</td><td align="left" valign="top">11.6 (8.2-25)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top">hyperthyroid</td><td align="left" valign="top">0.8 (0.68-0.97)</td><td align="left" valign="top">4.5 (3.7-5.6)</td><td align="left" valign="top"></td></tr>
<tr><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td><td align="left" valign="top"></td></tr>
</tbody>
</table>